Atherosclerotic risk is associated with cerebral perfusion - A cross-sectional study using arterial spin labeling MRI

Melanie Hafdi1, Henk Jmm Mutsaerts2, Jan Petr3

  • 1Department of Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Neuroimage. Clinical
|August 15, 2022
PubMed
Abstract

Insights

Arterial spin labeling (ASL) MRI

Area of Science:

  • Neuroimaging
  • Cardiovascular Research
  • Radiology

Background:

  • Cerebral atherosclerosis assessment using Arterial Spin Labeling (ASL) Magnetic Resonance Imaging (MRI) shows promise.
  • Investigating novel ASL MRI parameters for improved atherosclerotic risk evaluation.
  • Comparing ASL-sCoV against conventional markers like white matter hyperintensity (WMH) volume and ASL cerebral blood flow (ASL-CBF).

Purpose of the Study:

  • To determine if the ASL MRI parameter 'spatial coefficient of variation' (ASL-sCoV) is a superior radiological marker for atherosclerotic risk.
  • To compare ASL-sCoV's efficacy against WMH volume and ASL-CBF in older adults with hypertension.

Main Methods:

  • 195 participants (72-80 years) from the preDIVA trial underwent two MRI scans.
  • WMH volume derived from 3D FLAIR-MRI; ASL-CBF and ASL-sCoV from ASL-MRI.
  • 10-year cardiovascular risk calculated using Systematic COronary Risk Evaluation Older Persons (SCORE O.P) at baseline and follow-up; analyzed with linear regression.

Main Results:

  • ASL-sCoV associated with atherosclerotic risk at baseline and follow-up (p < 0.0001, p = 0.02).
  • ASL-CBF associated with risk at baseline (p < 0.001) but not follow-up (p = 0.12).
  • WMH volume showed no association with atherosclerotic risk scores.

Conclusions:

  • ASL-sCoV demonstrates a stronger correlation with atherosclerotic risk compared to ASL-CBF and WMH volume.
  • Non-invasive MRI imaging, particularly ASL-sCoV, provides valuable insights into cerebrovascular damage and atherosclerotic risk.
  • Findings support ASL-sCoV as a potentially superior radiological marker for assessing atherosclerotic risk.